Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
Fierce Biotech
Fri, 04/8/16 - 10:59 am
AstraZeneca
Eli Lilly
BACE inhibitors
Alzheimer's disease
AZD3293
$35M deal: Incyte licenses Lilly drug for potential new use
Bizjournals.com
Wed, 04/6/16 - 10:20 pm
Incyte
Eli Lilly
ruxolitinib
graft vs host disease
Insulin prices have skyrocketed, putting drug makers on the defensive
Stat
Wed, 04/6/16 - 09:56 am
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Medicare
Study shows no clinical benefit from Lilly cholesterol drug
BioPharma Dive
Mon, 04/4/16 - 09:50 am
Eli Lilly
evacetrapib
CTEP inhibitors
New cholesterol methods needed in wake of failed drugs, heart researchers say
Yahoo/Reuters
Sun, 04/3/16 - 10:53 am
cholesterol
Eli Lilly
Pfizer
Roche
Lilly's new arthritis drug beats placebo in latest successful trial
Fierce Biotech
Thu, 03/31/16 - 08:18 pm
Eli Lilly
clinical trials
baricitinib
rheumatoid arthritis
FDA approves Eli Lilly drug for psoriasis
Yahoo/Reuters
Wed, 03/23/16 - 09:43 am
FDA
Eli Lilly
psoriasis
ixekizumab
Will Eli Lilly's 11th-hour regulatory gambit salvage or sink its Alzheimer's drug?
Fierce Biotech
Tue, 03/22/16 - 10:02 am
Eli Lilly
Alzheimer's disease
solanezumab
Lilly Alzheimer's Study Change Piles Risk on Top of Risk
TheStreet.com
Tue, 03/15/16 - 10:18 pm
Eli Lilly
Alzheimer's disease
solanezumab
clinical trials
Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes
Bidness, ETC
Tue, 03/8/16 - 10:14 am
Novo Nordisk
Eli Lilly
Merck
diabetes
Victoza
Eli Lilly Aiming To Restart Growth With Pipeline Of Hot Drugs
Investors.com
Wed, 03/2/16 - 11:06 am
Eli Lilly
Drugmakers partner in immuno-oncology, to better capture market share
Medical Marketing and Media
Wed, 03/2/16 - 11:00 am
Opdivo
immuno-oncology
Bristol-Myers Squibb
Eli Lilly
Merck
Roche
AstraZeneca
Novartis
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
BioPharma Dive
Fri, 02/26/16 - 09:34 am
Eli Lilly
Portrazza
Europe
biologics
non-small cell lung cancer
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
BioPharma Dive
Wed, 02/24/16 - 04:48 pm
romosozumab
Amgen
osteoporosis
clinical trials
Eli Lilly
Forteo
Radius Health
abaloparatide
7 big pharma companies sign on to Parkinson's development group
BioPharma Dive
Wed, 02/24/16 - 11:49 am
R&D
AbbVie
AstraZeneca
Biogen
Eli Lilly
Merck
Pfizer
UCB Pharma
Parkinson's Disease
Eli Lilly and Co.’s 4Q15 Changes in Growth Rate
Yahoo/Market Realist
Sun, 02/14/16 - 11:04 am
Eli Lilly
Eli Lilly Just Lost the Latest Round in its Patent Battle
Fortune
Fri, 02/12/16 - 10:01 am
Eli Lilly
patents
Alimta
lung cancer
UK
Allergan
generics
Are the big M&A players in biopharma waiting out the bear market?
Fierce Biotech
Tue, 02/9/16 - 02:15 pm
M&A
Roche
Eli Lilly
Gilead Sciences
Sanofi
Biogen
Elanco’s 4Q15 Performance: Eli Lilly’s Animal Health Segment
Yahoo/Market Realist
Mon, 02/8/16 - 09:46 pm
Eli Lilly
animal health
Elanco
Pfizer keeps pushing on early hit Ibrance as Novartis, Lilly rivals near market
Fierce Pharma Marketing
Mon, 02/8/16 - 12:48 pm
Pfizer
Ibrance
breast cancer
Novartis
Eli Lilly
Pages
« first
‹ previous
…
71
72
73
74
75
76
77
78
79
…
next ›
last »